RecruitingNCT07682363

Management Concepts of Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Among Chinese Physicians

Attitudes, Perceptions, Clinical Practice, and Barriers in Diagnosis and Management of Patients With Metabolic Dysfunction-associated Steatotic Liver Disease: a Cross-sectional Survey on Physicians in China


Sponsor

Novo Nordisk A/S

Enrollment

470 participants

Start Date

Jun 3, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a cross-sectional survey-based study. The main goal of this study is to investigate the attitudes, perceptions, and clinical practice in assessing liver fibrosis following a metabolic dysfunction-associated steatotic liver disease (MASLD) diagnosis, and the management of MASLD patients among Chinese physicians in the departments of endocrinology / hepatology / infection / gastroenterology in Grade IIIA hospitals in provincial capitals or municipalities.


Eligibility

Min Age: 18 Years

Inclusion Criteria10

  • Has provided informed consent.
  • Registered clinical practice location in provincial capital or municipality.
  • Physician with a license for clinical practice.
  • Employed in the Department of Endocrinology, Hepatology, Infection or Gastroenterology.
  • Hospital level: Grade IIIA hospital.
  • Hold a professional title of associate chief physician or above, or senior attending physician (as an attending physician for more than or equal to (≥) 3 years).
  • Conducts outpatient clinics for at least 1 half-days per week.
  • The patient load of MASLD/MASH per month in the department should be:
  • a. Endocrinology ≥20 patients per month
  • b. Hepatology/Gastroenterology/ Infectious ≥30 patients per month

Exclusion Criteria1

  • Participants will be excluded if they have unwillingness precluding adequate cooperation, fail to complete the questionnaire, or submit questionnaires verified as invalid.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo treatment is given

This study is a cross-sectional survey-based study. The design is observational and descriptive. Collection of data will be performed via a quantitative online survey.


Locations(1)

Novo Nordisk Investigational site

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07682363


Related Trials